HCV synergizes with body weight in the promotion of insulin resistance.
about
Limiting the access to direct-acting antivirals against HCV: an ethical dilemma.Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin actionFactors Associated with Insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without Obesity or Type 2 Diabetes.
P2860
HCV synergizes with body weight in the promotion of insulin resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HCV synergizes with body weight in the promotion of insulin resistance.
@en
HCV synergizes with body weight in the promotion of insulin resistance.
@nl
type
label
HCV synergizes with body weight in the promotion of insulin resistance.
@en
HCV synergizes with body weight in the promotion of insulin resistance.
@nl
prefLabel
HCV synergizes with body weight in the promotion of insulin resistance.
@en
HCV synergizes with body weight in the promotion of insulin resistance.
@nl
P2093
P2860
P1476
HCV synergizes with body weight in the promotion of insulin resistance.
@en
P2093
A Delgado-Borrego
S H Jordan
Y Kamegaya
P2860
P304
P356
10.1111/J.1365-2893.2010.01291.X
P577
2011-02-01T00:00:00Z